# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY

I Background Information:

A 510(k) Number K232736 B Applicant

Chemtron Biotech, Inc.

# C Proprietary and Established Names

Chemtrue $\textsuperscript { \textregistered }$ Drug Screen Fentanyl/Tramadol Cup Test, Chemtrue $\textsuperscript { \textregistered }$ Drug Screen Fentanyl/Tramadol Dip Card Test, Chemtrue $\textsuperscript { \textregistered }$ Multi-Panel Drug Screen Cup Test, Chemtrue $\textsuperscript { \textregistered }$ Multi-Panel Drug Screen Dip Card Test.

# D Regulatory Information

<table><tr><td colspan="1" rowspan="1">ProductCode(s)</td><td colspan="1" rowspan="1">Classification</td><td colspan="1" rowspan="1">RegulationSection</td><td colspan="1" rowspan="1">Panel</td></tr><tr><td colspan="1" rowspan="1">DJG</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3650 -Opiate Test System</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">DKZ</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3100 -Amphetamine testsystem</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">DIS</td><td colspan="1" rowspan="1">Class I</td><td colspan="1" rowspan="1">21 CFR 862.3150 -Barbiturate testsystem</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">JXM</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3170 -Benzodiazepine testsystem</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">DIO</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3250 -Cocaine and cocainemetabolite test system</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">DJC</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3610 -Methamphetaminetest system</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">LDJ</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3870 -Cannabinoid testsystem</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">LAF</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3610 -Methamphetaminetest system</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">DJR</td><td colspan="1" rowspan="1">Class I</td><td colspan="1" rowspan="1">21 CFR 862.3620 -Methadone testsystem</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">DNK</td><td colspan="1" rowspan="1">Class I</td><td colspan="1" rowspan="1">21 CFR 862.3640 -Morphine test system</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">LCM</td><td colspan="1" rowspan="1">Unclassified</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">LFG</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3910 -Tricyclicantidepressant drugstest system</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr></table>

II Submission/Device Overview:

A Purpose for Submission: New device

# B Measurand:

d-Amphetamine, Secobarbital/Pentobarbital, Oxazepam, Buprenorphine, Benzoylecgonine, d,lMethylenedioxy methamphetamine, Norfentanyl, d-Methamphetamine, 11-nor- $\Delta 9$ -THC-9- COOH, Methadone, Morphine, Oxycodone, Phencyclidine, Propoxyphene, Nortriptyline, Tramadol

# C Type of Test:

III Intended Use/Indications for Use:

A Intended Use(s): See Indications for Use below.

# B Indication(s) for Use:

The Chemtrue $\textsuperscript { \textregistered }$ Drug Screen Fentanyl / Tramadol Dip Card Test is a rapid lateral flow immunoassay for the qualitative detection of Norfentanyl (FYL) 5 and Tramadol (TML) 100 drugs in human urine. It is an in vitro diagnostic device. The test cut-off concentrations and calibrators are listed below:

nalyte

Abbreviation Calibrator Cutoff Concentration $\mathrm { ( n g / m L ) }$

<table><tr><td>Norfentanyl</td><td>FYL</td><td>Norfentanyl</td><td>5</td></tr><tr><td>Tramadol</td><td>TML</td><td>Tramadol</td><td>100</td></tr></table>

The Chemtrue $\textsuperscript { \textregistered }$ Drug Screen Fentanyl / Tramadol Dip Card Test detects and is calibrated against norfentanyl, the major metabolite of fentanyl in human urine. The test is available in Single and multi-panels.

The test provides only a preliminary result. A more specific alternative chemical method must be used in order to obtain a confirmed assay result. Gas Chromatography / Mass Spectrometry (GC/MS) or Liquid Chromatography / Mass Spectrometry (LC/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to the drug test result, particularly when preliminary positive result is indicated.

The test is not intended to differentiate between drugs of abuse and prescription use of Fentanyl/ Tramadol. The test is for in vitro diagnostic use only.

The Chemtrue $\textsuperscript { \textregistered }$ Drug Screen Fentanyl / Tramadol Cup Test is a rapid lateral flow immunoassay for the qualitative detection of Norfentanyl (FYL) 5 and Tramadol (TML) 100 drugs in human urine. It is an in vitro diagnostic device. The test cut-off concentrations and calibrators are listed below:

<table><tr><td>Analyte</td><td>Abbreviation</td><td>Calibrator</td><td>Cutoff Concentration (ng/mL)</td></tr><tr><td>Norfentanyl</td><td>FYL</td><td>Norfentanyl</td><td>5</td></tr><tr><td>Tramadol</td><td>TML</td><td>Tramadol</td><td>100</td></tr></table>

The Chemtrue $\textsuperscript { \textregistered }$ Drug Screen Fentanyl / Tramadol Cup Test detects and is calibrated against norfentanyl, the major metabolite of fentanyl in human urine. The test is available in Single and multi-panels.

The test provides only a preliminary result. A more specific alternative chemical method must be used in order to obtain a confirmed assay result. Gas Chromatography / Mass Spectrometry (GC/MS) or Liquid Chromatography / Mass Spectrometry (LC/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to the drug test result, particularly when preliminary positive result is indicated.

The test is not intended to differentiate between drugs of abuse and prescription use of Fentanyl/ Tramadol. The test is for in vitro diagnostic use only.

The Chemtrue $\textsuperscript { \textregistered }$ Multi-Panel Drug Screen Dip Card Test is a rapid lateral flow immunoassay for the qualitative detection of Amphetamine, Barbiturates, Benzodiazepines, Buprenorphine, Cocaine, Ecstasy, Norfentanyl, Marijuana, Methamphetamine, Methadone, Morphine, Opiates, Oxycodone, Phencyclidine, Propoxyphene, Tramadol and Tricyclic Antidepressants (TCA) drugs in human urine. The test cut-off concentrations and the compounds the tests are calibrated to are as follows:

<table><tr><td>Analyte</td><td>Abbreviation Calibrator</td><td></td><td>Cutoff Concentration (ng/mL)</td></tr><tr><td>Amphetamine</td><td>AMP</td><td>d-Amphetamine</td><td>300</td></tr><tr><td>Amphetamine</td><td>AMP</td><td>d-Amphetamine</td><td>500</td></tr><tr><td>Amphetamine</td><td>AMP</td><td>d-Amphetamine</td><td>1,000</td></tr><tr><td>Barbiturates</td><td>BAR</td><td>Secobarbital/Pentobarbital</td><td>200</td></tr><tr><td>Barbiturates</td><td>BAR</td><td>Secobarbital/Pentobarbital</td><td>300</td></tr><tr><td>Benzodiazepines</td><td>BZO</td><td>Oxazepam</td><td>200</td></tr><tr><td>Benzodiazepines</td><td>BZO</td><td>Oxazepam</td><td>300</td></tr><tr><td>Buprenorphine</td><td>BUP</td><td>Buprenorphine</td><td>10</td></tr><tr><td>Cocaine</td><td>COC</td><td>Benzoylecgonine</td><td>150</td></tr><tr><td>Cocaine</td><td>COC</td><td>Benzoylecgonine</td><td>300</td></tr><tr><td>Ecstasy</td><td>MDMA</td><td>d,1-Methylenedioxy methamphetamine</td><td>500</td></tr><tr><td>Norfentanyl</td><td>FYL</td><td>Norfentanyl</td><td>5</td></tr><tr><td>Methamphetamine</td><td>MET</td><td>d-Methamphetamine</td><td>300</td></tr><tr><td>Methamphetamine</td><td>MET</td><td>d-Methamphetamine</td><td>500</td></tr><tr><td>Methamphetamine</td><td>MET</td><td>d-Methamphetamine</td><td>1,000</td></tr><tr><td>Marijuana</td><td>THC</td><td>11-nor-Δ9-THC-9-COOH</td><td>50</td></tr><tr><td>Methadone</td><td>MTD</td><td>Methadone</td><td>300</td></tr><tr><td>Morphine</td><td>MOR</td><td>Morphine</td><td>300</td></tr><tr><td>Opiates</td><td>OPI</td><td>Morphine</td><td>2,000</td></tr><tr><td>Oxycodone</td><td>OXY</td><td>Oxycodone</td><td>100</td></tr><tr><td>Phencyclidine</td><td>PCP</td><td>Phencyclidine</td><td>25</td></tr><tr><td>Propoxyphene</td><td>PPX</td><td>Propoxyphene</td><td>300</td></tr><tr><td>Tricyclic Antidepressants</td><td>TCA</td><td>Nortriptyline</td><td>1,000</td></tr><tr><td>Tramadol</td><td>TML</td><td>Tramadol</td><td>100</td></tr></table>

The multi test panels can consist of any drug analytes listed above in any combination. Only one cut-off concentration will be included per analyte per device.

The test provides only a preliminary result. A more specific alternative chemical method must be used in order to obtain a confirmed assay result. Gas Chromatography / Mass Spectrometry (GC/MS) or Liquid Chromatography / Mass Spectrometry (LC/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to any drugs of abuse test result, particularly when preliminary positive results are indicated.

The tests are not intended to differentiate between drugs of abuse and prescription use of Benzodiazepines, Barbiturates, Buprenorphine, Oxycodone, Propoxyphene and Tricyclic Antidepressants.

The Chemtrue $\textsuperscript { \textregistered }$ Multi-Panel Drug Screen Cup Test is a rapid lateral flow immunoassay for the qualitative detection of Amphetamine, Barbiturates, Benzodiazepines, Buprenorphine, Cocaine, Ecstasy, Norfentanyl, Marijuana, Methamphetamine, Methadone, Morphine, Opiates, Oxycodone, Phencyclidine, Propoxyphene, Tramadol and Tricyclic Antidepressants (TCA) drugs in human urine. The test cut-off concentrations and the compounds the tests are calibrated to are as follows:

<table><tr><td>Analyte</td><td>Abbreviation Calibrator</td><td></td><td>Cutoff Concentration (ng/mL)</td></tr><tr><td>Amphetamine</td><td>AMP</td><td>d-Amphetamine</td><td>300</td></tr><tr><td>Amphetamine</td><td>AMP</td><td>d-Amphetamine</td><td>500</td></tr><tr><td>Amphetamine</td><td>AMP</td><td>d-Amphetamine</td><td>1,000</td></tr><tr><td>Barbiturates</td><td>BAR</td><td>Secobarbital/Pentobarbital</td><td>200</td></tr><tr><td>Barbiturates</td><td>BAR</td><td>Secobarbital/Pentobarbital</td><td>300</td></tr><tr><td>Benzodiazepines</td><td>BZO</td><td>Oxazepam</td><td>200</td></tr><tr><td>Benzodiazepines</td><td>BZO</td><td>Oxazepam</td><td>300</td></tr><tr><td>Buprenorphine</td><td>BUP</td><td>Buprenorphine</td><td>10</td></tr><tr><td>Cocaine</td><td>COC</td><td>Benzoylecgonine</td><td>150</td></tr><tr><td>Cocaine</td><td>COC</td><td>Benzoylecgonine</td><td>300</td></tr><tr><td>Ecstasy</td><td>MDMA</td><td>d,1-Methylenedioxy methamphetamine</td><td>500</td></tr><tr><td>Norfentanyl</td><td>FYL</td><td>Norfentanyl</td><td>5</td></tr><tr><td>Methamphetamine</td><td>MET</td><td>d-Methamphetamine</td><td>300</td></tr><tr><td>Methamphetamine</td><td>MET</td><td>d-Methamphetamine</td><td>500</td></tr><tr><td>Methamphetamine</td><td>MET</td><td>d-Methamphetamine</td><td>1,000</td></tr><tr><td>Marijuana</td><td>THC</td><td>11-nor-Δ9-THC-9-COOH</td><td>50</td></tr><tr><td>Methadone</td><td>MTD</td><td>Methadone</td><td>300</td></tr><tr><td>Morphine</td><td>MOR</td><td>Morphine</td><td>300</td></tr><tr><td>Opiates</td><td>OPI</td><td>Morphine</td><td>2,000</td></tr><tr><td>Oxycodone</td><td>OXY</td><td>Oxycodone</td><td>100</td></tr><tr><td>Phencyclidine</td><td>PCP</td><td>Phencyclidine</td><td>25</td></tr><tr><td>Propoxyphene</td><td>PPX</td><td>Propoxyphene</td><td>300</td></tr><tr><td>Tricyclic Antidepressants</td><td>TCA</td><td>Nortriptyline</td><td>1,000</td></tr><tr><td>Tramadol</td><td>TML</td><td>Tramadol</td><td>100</td></tr></table>

The multi test panels can consist of any drug analytes listed above in any combination. Only one cut-off concentration will be included per analyte per device.

The test provides only a preliminary result. A more specific alternative chemical method must be used in order to obtain a confirmed assay result. Gas Chromatography / Mass Spectrometry (GC/MS) or Liquid Chromatography / Mass Spectrometry (LC/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to any drugs of abuse test result, particularly when preliminary positive results are indicated.

The tests are not intended to differentiate between drugs of abuse and prescription use of Benzodiazepines, Barbiturates, Buprenorphine, Oxycodone, Propoxyphene and Tricyclic Antidepressants.

C Special Conditions for Use Statement(s): OTC - Over The Counter   
D Special Instrument Requirements: Not applicable

IV Device/System Characteristics:

# A Device Description:

The devices are colloidal gold-based lateral flow immunoassays for the rapid, qualitative detection of drugs of abuse in human urine. The tests are single-use, in vitro diagnostic devices, which come in Dip Card or Cup formats, as indicated by the test name.

# B Principle of Operation:

These devices are rapid lateral flow immunoassays in which chemically modified drugs (drugprotein conjugates) compete with drugs that may be present in urine. On each test strip, a drugprotein conjugate is striped on the test band of the membrane - known as the test region (T) and the anti-drug antibody-colloidal gold conjugate pads are placed at the forward end of the membrane. If target drugs are present in the urine specimen below its cut-off concentration, the solution of the colored antibody-colloidal gold conjugates moves along with the sample solution by capillary action across the membrane to the immobilized drug-protein conjugate zone on the test band region. The colored antibody-gold conjugates then complexes with the drug-protein conjugates to form visible lines. Therefore, the formation of the visible precipitant in the test band indicates a negative result. If the target drug level exceeds its cut-off concentration, the drug/metabolite antigen competes with drug-protein conjugates on the test band region for the limited antibody on the colored drug antibody-colloidal gold conjugate pad. The drug will saturate the limited antibody binding sites and the colored antibody-colloidal gold conjugate cannot bind to the drug-protein conjugate at the test region of the test strip. Therefore, absence of the color band on the test region indicates a preliminary positive result.

A band should form in the control region (C) of the devices regardless of the presence of drug in the sample to indicate that the test has been performed properly.

# V Substantial Equivalence Information:

A Predicate Device Name(s): Chemtrue $\textsuperscript { \textregistered }$ Multi-Panel Drug Screen Cup/Dip Card Tests

B Predicate 510(k) Number(s): K153192

C Comparison with Predicate(s):

<table><tr><td colspan="1" rowspan="1">Device &amp; PredicateDevice(s):</td><td colspan="1" rowspan="1">K232736</td><td colspan="1" rowspan="1">K153192</td></tr><tr><td colspan="1" rowspan="1">Device Trade Name</td><td colspan="1" rowspan="1">Chemtrue® Drug ScreenFentanyl/TramadolCup/Dip Card TestsChemtrue® Multi-PanelDrug Screen Cup/ DipCard Tests</td><td colspan="1" rowspan="1">Chemtrue® Multi-PanelDrug Screen Cup/Dip CardTests</td></tr><tr><td colspan="1" rowspan="1">General DeviceCharacteristicSimilarities</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">IntendedUse/Indications ForUse</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Drugs of abuse testing inhuman urine</td></tr><tr><td colspan="1" rowspan="1">General DeviceCharacteristicDifferences</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Analytes</td><td colspan="1" rowspan="1">Amphetamine,Barbiturates,Benzodiazepines,Buprenorphine, Cocaine,</td><td colspan="1" rowspan="1">Amphetamine, Barbiturates,Benzodiazepines,Buprenorphine, Cocaine,Marijuana,</td></tr><tr><td></td><td>Marijuana, Methamphetamine, Morphine, Phencyclidine, Ecstasy, Methadone, Oxycodone, Propoxyphene, Tricyclic Antidepressants (TCA), Norfentanyl, and Tramadol</td><td>Methamphetamine, Morphine, Phencyclidine, Ecstasy, Methadone, Oxycodone, Propoxyphene and Tricyclic Antidepressants (TCA)</td></tr></table>

# VI Standards/Guidance Documents Referenced:

Not applicable

VII Performance Characteristics (if/when applicable):

# A Analytical Performance:

1. Precision/Reproducibility:

Precision/reproducibility studies were carried out for Norfentanyl- and Tramadol-spiked urine controls with LC/MS confirmed concentrations of $0 \%$ , $- 5 0 \%$ , $- 2 5 \%$ , $100 \%$ , $+ 2 5 \%$ and $+ 5 0 \%$ of the drug cutoff. The samples were blind coded and randomly assigned to 3 operators over 5 days of testing.

Precision performance for the remaining drugs (d-Amphetamine, Secobarbital/Pentobarbital, Oxazepam, Buprenorphine, Benzoylecgonine, d,l-Methylenedioxy methamphetamine, dMethamphetamine, 11-nor- $\cdot \Delta 9$ -THC-9-COOH, Methadone, Morphine, Oxycodone, Phencyclidine, Propoxyphene, Nortriptyline) was established in k142396 and k153192.

# Dip Card Format

<table><tr><td rowspan=1 colspan=1>Test</td><td rowspan=1 colspan=1>ConcentrationTested</td><td rowspan=1 colspan=1>Lot 1Neg/Pos</td><td rowspan=1 colspan=1>Lot 2Neg/Pos</td><td rowspan=1 colspan=1>Lot 3Neg/Pos</td><td rowspan=1 colspan=1>TotalNeg/Pos</td></tr><tr><td rowspan=6 colspan=1>FYL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>30/0</td></tr><tr><td rowspan=1 colspan=1>50% of cutoff</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>30/0</td></tr><tr><td rowspan=1 colspan=1>75% of cutoff</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>30/0</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>2/8</td><td rowspan=1 colspan=1>1/9</td><td rowspan=1 colspan=1>2/8</td><td rowspan=1 colspan=1>5/25</td></tr><tr><td rowspan=1 colspan=1>125% of cutoff</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/30</td></tr><tr><td rowspan=1 colspan=1>150% of cutoff</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/30</td></tr><tr><td rowspan=6 colspan=1>TML</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>30/0</td></tr><tr><td rowspan=1 colspan=1>50% of cutoff</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>30/0</td></tr><tr><td rowspan=1 colspan=1>75% of cutoff</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>30/0</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>1/9</td><td rowspan=1 colspan=1>3/7</td><td rowspan=1 colspan=1>1/9</td><td rowspan=1 colspan=1>5/25</td></tr><tr><td rowspan=1 colspan=1>125% of cutoff</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/30</td></tr><tr><td rowspan=1 colspan=1>150% of cutoff</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/30</td></tr></table>

Cup Format   

<table><tr><td rowspan=1 colspan=1>Test</td><td rowspan=1 colspan=1>ConcentrationTested</td><td rowspan=1 colspan=1>Lot 1Neg/Pos</td><td rowspan=1 colspan=1>Lot 2Neg/Pos</td><td rowspan=1 colspan=1>Lot 3Neg/Pos</td><td rowspan=1 colspan=1>TotalNeg/Pos</td></tr><tr><td rowspan=6 colspan=1>FYL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>30/0</td></tr><tr><td rowspan=1 colspan=1>50% of cutoff</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>30/0</td></tr><tr><td rowspan=1 colspan=1>75% of cutoff</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>30/0</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>1/9</td><td rowspan=1 colspan=1>1/9</td><td rowspan=1 colspan=1>2/8</td><td rowspan=1 colspan=1>4/26</td></tr><tr><td rowspan=1 colspan=1>125% of cutoff</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/30</td></tr><tr><td rowspan=1 colspan=1>150% of cutoff</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/30</td></tr><tr><td rowspan=6 colspan=1>TML</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>30/0</td></tr><tr><td rowspan=1 colspan=1>50% of cutoff</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>30/0</td></tr><tr><td rowspan=1 colspan=1>75% of cutoff</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>10/0</td><td rowspan=1 colspan=1>30/0</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>1/9</td><td rowspan=1 colspan=1>3/7</td><td rowspan=1 colspan=1>2/8</td><td rowspan=1 colspan=1>6/24</td></tr><tr><td rowspan=1 colspan=1>125% of cutoff</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/30</td></tr><tr><td rowspan=1 colspan=1>150% of cutoff</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/10</td><td rowspan=1 colspan=1>0/30</td></tr></table>

2. Linearity:

Not applicable. These devices are intended for qualitative use only.

# 3. Analytical Specificity/Interference:

For each drug and cutoff, specificity was evaluated by spiking various concentrations of similarly structured drug compounds into drug-free urine. Results are expressed as a minimum concentration of metabolite or compound required to produce a response approximately equivalent to the cutoff concentration of the assay. The percent cross reactivity of those compounds is listed below (if no cross reactivity was observed, the highest concentration tested is shown as $< 1 \%$ ):

Norfentanyl-related compounds:   

<table><tr><td colspan="1" rowspan="1">Substances</td><td colspan="1" rowspan="1">Concentration ng/mL</td><td colspan="1" rowspan="1">% Cross Reactivity</td></tr><tr><td colspan="1" rowspan="1">Norfentanyl</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Fentanyl</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">4-Fluoro-isobutyryl Fentanyl</td><td colspan="1" rowspan="1">&gt;20,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">9-HydroxyRisperidone</td><td colspan="1" rowspan="1">10,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Acetyl Fentanyl</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">2.5</td></tr><tr><td colspan="1" rowspan="1">Acetyl Norfentanyl</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">2.5</td></tr><tr><td colspan="1" rowspan="1">(±)-β-Hydroxythiofentanyl Hcl</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">25</td></tr><tr><td colspan="1" rowspan="1">Acryl Fentanyl</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">16.7</td></tr><tr><td colspan="1" rowspan="1">Alfentanil</td><td colspan="1" rowspan="1">1,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Butyryl Fentanyl</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">33.3</td></tr><tr><td colspan="1" rowspan="1">Carfentanil Oxalate</td><td colspan="1" rowspan="1">&gt;10,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Cis-d, I 3-Methylfentanyl</td><td colspan="1" rowspan="1">70</td><td colspan="1" rowspan="1">7.1</td></tr><tr><td colspan="1" rowspan="1">Despropionylfentanyl (4-ANPP)</td><td colspan="1" rowspan="1">&gt;20,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Furanyl Fentanyl</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">6.25</td></tr><tr><td colspan="1" rowspan="1">Isobutyryl Fentanyl</td><td colspan="1" rowspan="1">5,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Labetalol Hydrochloride</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">MT-45</td><td colspan="1" rowspan="1">7,500</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Norcarfentail Oxalate</td><td colspan="1" rowspan="1">&gt;20,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Ocfentanil</td><td colspan="1" rowspan="1">1,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Para-fluoro butyrl Fentanyl (P-FBF)</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">25</td></tr><tr><td colspan="1" rowspan="1">para-Fluorofentanyl</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="1" rowspan="1">Remifentanil</td><td colspan="1" rowspan="1">&gt;20,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Risperidone</td><td colspan="1" rowspan="1">10,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Sufentanil</td><td colspan="1" rowspan="1">3,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Thienyl Fentnayl</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">12.5</td></tr><tr><td colspan="1" rowspan="1">Trans-d, I 3-Methylfentanyl</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">16.7</td></tr><tr><td colspan="1" rowspan="1">Trazodone</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">U-47700</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Valeryl Fentanyl</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr></table>

Tramadol related compounds:   

<table><tr><td rowspan=1 colspan=1>Substances</td><td rowspan=1 colspan=1>Concentration ng/mL</td><td rowspan=1 colspan=1>% Cross Reactivity</td></tr><tr><td rowspan=1 colspan=1>Tramadol</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>n-Desmethyl Tramadol</td><td rowspan=1 colspan=1>400</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>o-Desmethyl Tramadol</td><td rowspan=1 colspan=1>1,000</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>Venlafaxine</td><td rowspan=1 colspan=1>&gt;100,000</td><td rowspan=1 colspan=1>&lt;1</td></tr><tr><td rowspan=1 colspan=1>o-Desmethyl Venlafaxine</td><td rowspan=1 colspan=1>&gt;10,000</td><td rowspan=1 colspan=1>&lt;1</td></tr></table>

The sponsor also evaluated the potential for positive and negative interference from nonstructurally related compounds, endogenous compounds, $\mathsf { p H }$ , and specific gravity using samples containing drugs at $\pm 2 5 \%$ of the respective drug cutoff concentrations.

The following endogenous compounds showed no interference when tested at $1 0 0 ~ \mathrm { \mu g / m L }$   

<table><tr><td rowspan=1 colspan=1>Albumin</td><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>r-Globulin</td><td rowspan=1 colspan=1>Octopamine</td></tr><tr><td rowspan=1 colspan=1>Acetone</td><td rowspan=1 colspan=1>Dopamine</td><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>Riboflavin</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>Ethanol</td><td rowspan=1 colspan=1>Human serumAlbumin</td><td rowspan=1 colspan=1>SodiumChloride</td></tr><tr><td rowspan=1 colspan=1>Atropine</td><td rowspan=1 colspan=1>Galactose</td><td rowspan=1 colspan=1>B-HydroxybutyricAcid(F)</td><td rowspan=1 colspan=1>Uric Acid</td></tr><tr><td rowspan=1 colspan=1>Bilirubin</td><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>Oxalic Acid</td><td rowspan=1 colspan=1>Urea</td></tr><tr><td rowspan=1 colspan=1>Cholesterol</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr></table>

The following structurally unrelated compounds showed no interference when tested at 100 µg/mL:

<table><tr><td colspan="1" rowspan="1">Amlodipine besylate</td><td colspan="1" rowspan="1">I-Erythromycin</td><td colspan="1" rowspan="1">Norethindrone</td></tr><tr><td colspan="1" rowspan="1">7-Aminonitrazepam</td><td colspan="1" rowspan="1">Estradiol</td><td colspan="1" rowspan="1">Noscapine</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">Estrone</td><td colspan="1" rowspan="1">Octopamine</td></tr><tr><td colspan="1" rowspan="1">Ampicillin</td><td colspan="1" rowspan="1">Fenfluramine</td><td colspan="1" rowspan="1">Papaverine</td></tr><tr><td colspan="1" rowspan="1">Apomorphine</td><td colspan="1" rowspan="1">Fenofibrate</td><td colspan="1" rowspan="1">Penicillin-G</td></tr><tr><td colspan="1" rowspan="1">Aspirin</td><td colspan="1" rowspan="1">Fluphenazine(F)</td><td colspan="1" rowspan="1">Pentazocine</td></tr><tr><td colspan="1" rowspan="1">Aspartame</td><td colspan="1" rowspan="1">Fotemustine</td><td colspan="1" rowspan="1">Perphenazine</td></tr><tr><td colspan="1" rowspan="1">Baclofen</td><td colspan="1" rowspan="1">Furosemide</td><td colspan="1" rowspan="1">Phenelzine</td></tr><tr><td colspan="1" rowspan="1">Benzocaine6</td><td colspan="1" rowspan="1">Gemfibrozil</td><td colspan="1" rowspan="1">Phenylethylamine</td></tr><tr><td colspan="1" rowspan="1">Benzylpiperiazine</td><td colspan="1" rowspan="1">Guaiacolglyceryl ether</td><td colspan="1" rowspan="1">Phentermine</td></tr><tr><td colspan="1" rowspan="1">Benzoic Acid</td><td colspan="1" rowspan="1">Gentisic acid</td><td colspan="1" rowspan="1">Prednisone</td></tr><tr><td colspan="1" rowspan="1">4-Bromo-2,5,Dimethoxyphenethylamine</td><td colspan="1" rowspan="1">Hexobarbital</td><td colspan="1" rowspan="1">Promazine</td></tr><tr><td colspan="1" rowspan="1">Carisoprodol</td><td colspan="1" rowspan="1">Hydralazine</td><td colspan="1" rowspan="1">Promethazine</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">Hydrocortisone</td><td colspan="1" rowspan="1">Propoxyphene</td></tr><tr><td colspan="1" rowspan="1">Cetirizine</td><td colspan="1" rowspan="1">3-Hydroxytyramine</td><td colspan="1" rowspan="1">Propranolol</td></tr><tr><td colspan="1" rowspan="1">Chloramphenicol</td><td colspan="1" rowspan="1">β-Hydroxybutyric Acid</td><td colspan="1" rowspan="1">Pyridoxine</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide</td><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">Pyrilamine</td></tr><tr><td colspan="1" rowspan="1">Chlorpheniramine</td><td colspan="1" rowspan="1">d,1-Isoproterenol</td><td colspan="1" rowspan="1">Pyrogallol</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">Norpropoxyphene</td></tr><tr><td colspan="1" rowspan="1">Clofibrate</td><td colspan="1" rowspan="1">Lamotrigine</td><td colspan="1" rowspan="1">Quinidine</td></tr><tr><td colspan="1" rowspan="1">Clonidine</td><td colspan="1" rowspan="1">Lisinopril</td><td colspan="1" rowspan="1">Quinine</td></tr><tr><td colspan="1" rowspan="1">Cortisone</td><td colspan="1" rowspan="1">Loratidine</td><td colspan="1" rowspan="1">Quinolinic Acid</td></tr><tr><td colspan="1" rowspan="1">I-Cotinine</td><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">Ranitidine</td></tr><tr><td colspan="1" rowspan="1">Creatine Hydrate</td><td colspan="1" rowspan="1">Meprobamate</td><td colspan="1" rowspan="1">Salicylic Acid</td></tr><tr><td colspan="1" rowspan="1">Cyclobenzaprine</td><td colspan="1" rowspan="1">Metoprolol</td><td colspan="1" rowspan="1">Sodium Azide</td></tr><tr><td colspan="1" rowspan="1">Cyclodextrin-r</td><td colspan="1" rowspan="1">Methapyrilene</td><td colspan="1" rowspan="1">Sulfamethazine</td></tr><tr><td colspan="1" rowspan="1">Cyproheptadine</td><td colspan="1" rowspan="1">Methylphenidate</td><td colspan="1" rowspan="1">Sulindac</td></tr><tr><td colspan="1" rowspan="1">Demoxepam</td><td colspan="1" rowspan="1">Nalidixic Acid</td><td colspan="1" rowspan="1">Tetracycline</td></tr><tr><td colspan="1" rowspan="1">Deoxycorticosterone</td><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">Tetrahydrozoline</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">Thiamine</td></tr><tr><td colspan="1" rowspan="1">Diclofenac</td><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">Thioridazine</td></tr><tr><td colspan="1" rowspan="1">Diflunisal</td><td colspan="1" rowspan="1">Niacinamide</td><td colspan="1" rowspan="1">Trifluoromethylphenyl-piperazine</td></tr><tr><td colspan="1" rowspan="1">Dimethyl-aminoantipyrine</td><td colspan="1" rowspan="1">N-desmethylapentadol</td><td colspan="1" rowspan="1">Trifluoperazine</td></tr><tr><td colspan="1" rowspan="1">Diphenhydramine</td><td colspan="1" rowspan="1">Nicotinic Acid</td><td colspan="1" rowspan="1">Tryptamine</td></tr><tr><td colspan="1" rowspan="1">Diphenylhydantoin</td><td colspan="1" rowspan="1">Nifedipine</td><td colspan="1" rowspan="1">Tyramine</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Zolpidem</td></tr></table>

The following compounds showed no interference to the detection of Norfentanyl/Tramadol when tested at the following concentrations:

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>Conc. (ng/mL)</td><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>Conc. (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>Acetylsalicylic Acid</td><td rowspan=1 colspan=1>500,000</td><td rowspan=1 colspan=1>Metformin</td><td rowspan=1 colspan=1>25,000</td></tr><tr><td rowspan=1 colspan=1>7-Aminoflunitrazepam</td><td rowspan=1 colspan=1>25,000</td><td rowspan=1 colspan=1>Norpseudoephedrine</td><td rowspan=1 colspan=1>25,000</td></tr><tr><td rowspan=1 colspan=1>Bupropion</td><td rowspan=1 colspan=1>25,000</td><td rowspan=1 colspan=1>Oxazepam Glucuronide</td><td rowspan=1 colspan=1>25,000</td></tr><tr><td rowspan=1 colspan=1>Caffeine</td><td rowspan=1 colspan=1>500,000</td><td rowspan=1 colspan=1>Sufentanil Citrate</td><td rowspan=1 colspan=1>25,000</td></tr><tr><td rowspan=1 colspan=1>Carbamazepine</td><td rowspan=1 colspan=1>25,000</td><td rowspan=1 colspan=1>11-nor-9 carboxy THC</td><td rowspan=1 colspan=1>50,000</td></tr><tr><td rowspan=1 colspan=1>Lorazepam Glucuronide</td><td rowspan=1 colspan=1>50,000</td><td rowspan=1 colspan=1>L-thyroxine</td><td rowspan=1 colspan=1>25,000</td></tr><tr><td rowspan=1 colspan=1>LSD</td><td rowspan=1 colspan=1>50,000</td><td rowspan=1 colspan=1>Zolpidem Tartrate</td><td rowspan=1 colspan=1>50,000</td></tr></table>

The following opioids showed no interference when tested at $1 0 0 ~ \mathrm { \mu g / m L }$   

<table><tr><td colspan="1" rowspan="1">6-Acetylmorphine</td><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">Norcodeine</td></tr><tr><td colspan="1" rowspan="1">Amphetamine</td><td colspan="1" rowspan="1">Levorphanol</td><td colspan="1" rowspan="1">Norketamine</td></tr><tr><td colspan="1" rowspan="1">Buprenorphine</td><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">Normorphine</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">Noroxycodone</td></tr><tr><td colspan="1" rowspan="1">Dihydrocodeine</td><td colspan="1" rowspan="1">Morphine-3-glucuronide</td><td colspan="1" rowspan="1">Oxycodone</td></tr><tr><td colspan="1" rowspan="1">EDDP</td><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">Oxymorphone</td></tr><tr><td colspan="1" rowspan="1">Fluoxetine</td><td colspan="1" rowspan="1">norbuprenorphine</td><td colspan="1" rowspan="1">Pentazocine (Talwin)</td></tr><tr><td colspan="1" rowspan="1">Heroin</td><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">Tramadol</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">Morphine-3-glucuronide</td><td colspan="1" rowspan="1"></td></tr></table>

The following opioid compounds/drugs showed no interference when tested at 10 µg/mL:

<table><tr><td>Meperidine</td><td>Normeperidine</td><td>Risperidone</td></tr></table>

To evaluate the effect of pH value on the test results, urine controls $1 t \pm 2 5 \%$ of the cutoff value were used. Each control level was adjusted by either 1N NaOH solution or 1N HCl to pH levels of 2.0, 3.0, 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, 8.0 and 9.0. Each test sample was tested in duplicate.

To evaluate the effect of specific gravity, urine controls at $\pm 2 5 \%$ of the cutoff values were spiked with deionized water or sugar to obtain specific gravities of 1.001, 1.010, 1.015, 1.020, 1.025, and 1.030. Each test sample was tested in duplicate.

The results demonstrated that pH and specific gravity do not affect the results from the device at the conditions tested.

The analytical specificity performance for the remaining drugs (d-Amphetamine, Secobarbital/Pentobarbital, Oxazepam, Buprenorphine, Benzoylecgonine, d,lMethylenedioxy methamphetamine, d-Methamphetamine, 11-nor- $\Delta 9$ -THC-9-COOH, Methadone, Morphine, Oxycodone, Phencyclidine, Propoxyphene, Nortriptyline) was established in k142396 and k153192.

4. Assay Reportable Range:

Characterization of how the device performs analytically around the claimed cutoff concentration appears in the precision section VII.A.1 above.

5. Traceability, Stability, Expected Values (Controls, Calibrators, or Methods): All drug calibrators of the device are traceable to available commercial reference materials.

6. Detection Limit: Characterization of how the device performs at low concentrations appears in the precision section, VII.A.1, above.

# 7. Assay Cut-Off:

Characterization of how the device performs analytically around the claimed cutoff concentration appears in the precision section, VII.A.1, above.

# B Comparison Studies:

1. Method Comparison with Predicate Device:

The sponsor performed a method comparison study comparing the performance of the test strips to the LC/MS reference method. The results are summarized below:

<table><tr><td rowspan=4 colspan=1>Chemtrue®Drug ScreenDip Card</td><td rowspan=1 colspan=5>Concentration By LC/MS (ng/mL)</td></tr><tr><td rowspan=1 colspan=3>()</td><td rowspan=1 colspan=2>(+)</td></tr><tr><td rowspan=2 colspan=1>No drugpresent</td><td rowspan=1 colspan=2>Negative</td><td rowspan=2 colspan=1>Near cutoff positive(Cutoff to 150% ofthe cutoff)</td><td rowspan=2 colspan=1>Positive(&gt;150% of thecutoff)</td></tr><tr><td rowspan=1 colspan=1>&lt; 50% ofthe cutoff</td><td rowspan=1 colspan=1>50% of thecutoff tothe cutoff</td></tr><tr><td rowspan=1 colspan=1>FYL 5   (+)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>29</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>TML100(+)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>23</td></tr><tr><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

<table><tr><td rowspan=4 colspan=1>ChemtrueDrug ScreenCup</td><td rowspan=1 colspan=5>Concentration By LC/MS (ng/mL)</td></tr><tr><td rowspan=1 colspan=3>(-)</td><td rowspan=1 colspan=2>(+)</td></tr><tr><td rowspan=2 colspan=1>No drugpresent</td><td rowspan=1 colspan=2>Negative</td><td rowspan=2 colspan=1>Near cutoff positive(Cutoff to 150% ofthe cutoff)</td><td rowspan=2 colspan=1>Positive(&gt;150% of thecutoff)</td></tr><tr><td rowspan=1 colspan=1>&lt; 50% ofthe cutoff</td><td rowspan=1 colspan=1>50% of thecutoff tothe cutoff</td></tr><tr><td rowspan=1 colspan=1>FYL 5    (+)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>29</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>TML100 (+)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>23</td></tr><tr><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

\*This sample was found to contain fentanyl at concentrations that contributed to the observed positive result.

The analytical accuracy of the remaining drugs (d-Amphetamine, Secobarbital/Pentobarbital, Oxazepam, Buprenorphine, Benzoylecgonine, d,l-Methylenedioxy methamphetamine, dMethamphetamine, 11-nor- $\cdot \Delta 9$ -THC-9-COOH, Methadone, Morphine, Oxycodone, Phencyclidine, Propoxyphene, Nortriptyline) was established in k142396 and k153192.

2. Matrix Comparison: Not applicable. These devices are for use with urine samples only.

# C Clinical Studies:

1. Clinical Sensitivity: Not applicable.

2. Clinical Specificity:

Not applicable.

3. Other Clinical Supportive Data (When 1. and 2. Are Not Applicable):

A consumer study was performed for all analytes to evaluate the ability of untrained users to interpret the devices properly when given only the labeling (package insert) provided with the devices. Lay-users (140) participated in this study from 3 intended user sites with LC/MS confirmed urine samples in the following concentration ranges: negative, $50 \%$ , $7 5 \%$ , $12 5 \%$ and $1 5 0 \%$ of the cutoff. Samples were created by spiking drugs into drug-free urine pool. Each sample was aliquoted into an individual blind-labeled container. Each lay-user was provided with a package insert in English only, 2 blind-coded samples, and one each of the test devices (Cup/Dip Card format). The results are summarized below:

<table><tr><td colspan="2" rowspan="2">Chemtrue®Drug ScreenDip Card</td><td colspan="3" rowspan="1">LC/MS Negative</td><td colspan="2" rowspan="1">LC/MS Positive</td><td colspan="1" rowspan="2">% Agreementwith LC/MSvalues</td></tr><tr><td colspan="1" rowspan="1">NoDrugPresent</td><td colspan="1" rowspan="1">50% ofthecutoff</td><td colspan="1" rowspan="1">75% ofthecutoff</td><td colspan="1" rowspan="1">125%of thecutoff</td><td colspan="1" rowspan="1">150%of thecutoff</td></tr><tr><td colspan="1" rowspan="2">AMP1000</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">AMP500</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">47</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">AMP300</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">47</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">BAR300</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">BAR200</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">BUP10</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">BZO300</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">BZO200</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">COC300</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">COC150</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">FYL5</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">MDMA500</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">99%</td></tr><tr><td colspan="1" rowspan="2">MET1000</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">MET500</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">47</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">MET300</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">47</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">MTD300</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">MOR300</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">37</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">OXY100</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">99%</td></tr><tr><td colspan="1" rowspan="2">OPI2000</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">37</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">PCP25</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">98%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">PPX300</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">TCA1000</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">THC50</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">98%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">TML100</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr></table>

<table><tr><td colspan="2" rowspan="2">Chemtrue® Drug ScreenCup</td><td colspan="3" rowspan="1">LC/MS Negative</td><td colspan="2" rowspan="1">LC/MS Positive</td><td colspan="1" rowspan="2">% Agreementwith LC/MSvalues</td></tr><tr><td colspan="1" rowspan="1">NoDrugPresent</td><td colspan="1" rowspan="1">50% ofthecutoff</td><td colspan="1" rowspan="1">75% ofthecutoff</td><td colspan="1" rowspan="1">125%of thecutoff</td><td colspan="1" rowspan="1">150%of thecutoff</td></tr><tr><td colspan="1" rowspan="2">AMP1000</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">AMP500</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">47</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">AMP300</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">47</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">BAR300</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">BAR200</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">BUP10</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">BZO300</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">BZO200</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">COC300</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">COC150</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">FYL5</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">MDMA500</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">99%</td></tr><tr><td colspan="1" rowspan="2">MET1000</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">MET500</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">47</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">MET300</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">47</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">99%</td></tr><tr><td colspan="1" rowspan="2">MTD300</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">98%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">MOR300</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">37</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">OXY100</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">99%</td></tr><tr><td colspan="1" rowspan="2">OPI2000</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">37</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">PCP25</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">99%</td></tr><tr><td colspan="1" rowspan="2">PPX300</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">TCA1000</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">98%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">THC50</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">TML100</td><td colspan="1" rowspan="1">(+)</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr></table>

# D Clinical Cut-Off:

# E Expected Values/Reference Range:

# VIII Proposed Labeling:

The labeling supports the finding of substantial equivalence for this device.

# IX Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.